In this regard, the markers NeuN and MAP-2 were used to measure cytotoxicity and also to confirm their maturity and neuronal nature; these markers are employed in the study of different neurodegenerative diseases, such as Parkinson’s or Alzheimer’s [45,46]. This evidence concerns the gene MAP2 and neurodegenerative disease.